Products for Research Use Only

Niraparib tosylate monohyrate

CAT: 0013-GTR19164779-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19164779-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Niraparib (MK-4827) is a potent PARP inhibitor that disrupts the base-excision DNA repair pathway, leading to genomic instability and apoptosis in cancer cells. It is widely used in oncology research, particularly for studying BRCA-mutant cancers, and has demonstrated efficacy in both in vitro assays and in vivo tumor models.
CAS Number
1613220-15-7
Product Name Alternative
Inhibitor, inhibit, MK-4827 tosylate, Niraparib tosylate, Niraparib tosylate monohyrate, orally, lung, PARP, DNA, damage, breast, anti-tumor, Apoptosis, cancer, bioavailable, poly ADP ribose polymerase, ovarian
Field of Research
Cell Biology, Epigenetics & Chromatin, Molecular Biology, Pharmacology & Drug Discovery
Purity
97.70% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.92 mM) ; H2O:1 mg/mL (1.96 mM) ; DMSO:247.5 mg/mL (484.71 mM)
Smiles
CC1=CC=C (S (=O) (O) =O) C=C1.O=C (N) C (C2=N3) =CC=CC2=CN3C (C=C4) =CC=C4[C@@H]5CCCNC5.O
Molecular Formula
C26H30N4O5S
Molecular Weight
510.61
Storage Conditions
-20°C
Notes
For research use only.

Chemical Information

Niraparib tosylate monohydrate

Niraparib Tosylate Monohydrate is an orally bioavailable, hydrated, tosylate salt form of niraparib, an inhibitor of poly (ADP-ribose) polymerase (PARP) types 1 and 2 (PARP-1 and -2), with antineoplastic activity. Upon administration, niraparib binds to and inhibits the activity of PARP-1 and -2, thereby inhibiting PARP-1 and -2-mediated DNA repair, enhancing the accumulation of DNA strand breaks, promoting genomic instability and resulting in apoptosis. The PARP family of proteins catalyzes post-translational ADP-ribosylation of nuclear proteins and is activated by single-strand DNA (ssDNA) breaks.

CAS Number1613220-15-7
PubChem CID74763937
IUPAC Name4-methylbenzenesulfonic acid;2-[4-[(3S)-piperidin-3-yl]phenyl]indazole-7-carboxamide;hydrate
Molecular FormulaC26H30N4O5S
Molecular Weight510.6
Topological Polar Surface Area137
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count7
Rotatable Bond Count4
Heavy Atom Count36
Formal Charge0
Complexity655
SMILES
CC1=CC=C(C=C1)S(=O)(=O)O.C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N.O
InChI
InChI=1S/C19H20N4O.C7H8O3S.H2O/c20-19(24)17-5-1-3-15-12-23(22-18(15)17)16-8-6-13(7-9-16)14-4-2-10-21-11-14;1-6-2-4-7(5-3-6)11(8,9)10;/h1,3,5-9,12,14,21H,2,4,10-11H2,(H2,20,24);2-5H,1H3,(H,8,9,10);1H2/t14-;;/m1../s1
InChIKey
ACNPUCQQZDAPJH-FMOMHUKBSA-N
Chemical Structure
2D Structure
2D structure of Niraparib tosylate monohydrate
CAS: 1613220-15-7
CID: 74763937
Formula: C26H30N4O5S
MW: 510.6
Interactive 3D Structure
Loading 3D structure...
Computed Properties
PropertyValue
Molecular Weight510.6
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count7
Rotatable Bond Count4
Exact Mass510.19369124
Monoisotopic Mass510.19369124
Topological Polar Surface Area137 Ų
Heavy Atom Count36
Formal Charge0
Complexity655
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count3
Compound Is CanonicalizedYes